Replies to post #454342 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

When the Results Appear

---if you have any Wall St. connections do inform them of this positive development---

I have no such connections; just the website connection to my brokerage (which I used this morning to buy a few more AVXLs).

This Anavex 3-71/Schizophrenia study, itself, won't cause a change in the AVXL share price until clinical results emerge. Given the short duration of the study, in two short parts, A and B, 10 and 28 days respectively, results should appear by sometime this summer.

Of course, both the patients and their families will note any symptomatic improvements, should they occur, Will they keep those observations silent? Or, do they tell friends and family members, and others they know with the disease? If Anavex 3-71 produces prompt and strong therapeutic results, those will become widely known. Schizophrenia support groups will talk about and share what they learn. For both schizophrenia patients and Anavex Life Sciences Corp, the second half of 2024 could be quite rewarding.